Other Titles
Global Nursing Research: Medication Related Randomized Controlled Trials
Abstract
Session presented on Saturday, July 26, 2014:
Purpose: This randomized controlled trial, using a repeated measures control group design, tested the effectiveness of a 6-session medication adherence program for Chinese outpatients with schizophrenia and its subtypes over a 12-month follow-up.
Methods: A two-site controlled trial was conducted with 134 Chinese patients with psychotic disorders in Hong Kong. The program is a motivational and insight-inducing educational program that addresses patients' awareness and knowledge of schizophrenia and skills of medication management (Gray et al., 2006) . They were randomly assigned to either the medication adherence program or usual psychiatric outpatient care. The patients' levels of medication adherence (using Drug Attitude Inventory, DAI), mental (Positive and Negative Syndrome Scale, PANSS) and psychosocial (Specific Level of Functioning scale, SLOF) functioning, insights into illness (Insight and Treatment Attitude Questionnaire, ITAQ), and re-hospitalization rates (number and length in six months) were measured at recruitment and at one week (Post-test 1) and 12 months (Post-test 2) after the intervention.
Results: Preliminary results of MANOVA test indicated that the participants in the NPP reported significantly overall improvements on the patient outcomes [F (1, 132) = 6.12, p=0.005; Wilks' Lambda= 0.95; a large effect with partial (eta)2 = 0.39]. Post hoc Tukey's HSD test indicated that their mental state (PANSS score), attitude towards medication use (DAI score), and insight into the illness (ITAQ scores) were significantly improved and hospitalization rates (both number and length of re-admissions) were significantly reduced at both one week and 12 months after the intervention, compared with standard care.
Conclusion: The results of this controlled trial can provide evidence of the effectiveness of a community-based adherence therapy for schizophrenia in improving medication adherence, mental condition and insight into the illness and its treatment. This can then result in reducing the risk of relapse and re-admission over 12 months, and hence minimize those tragic events in relation to relapse such as violence and self-harm, as well as the medical and social costs.
Sigma Membership
Unknown
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Motivational Technique, Medication Adherence, Randomised Controlled Trial
Recommended Citation
Chien, Wai Tong; Mui, Jolene; and Cheung, Eric, "A RCT of the effects of medication adherence therapy for people with schizophrenia specturm disorders" (2014). INRC (Congress). 358.
https://www.sigmarepository.org/inrc/2014/presentations_2014/358
Conference Name
25th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Hong Kong
Conference Year
2014
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
A RCT of the effects of medication adherence therapy for people with schizophrenia specturm disorders
Hong Kong
Session presented on Saturday, July 26, 2014:
Purpose: This randomized controlled trial, using a repeated measures control group design, tested the effectiveness of a 6-session medication adherence program for Chinese outpatients with schizophrenia and its subtypes over a 12-month follow-up.
Methods: A two-site controlled trial was conducted with 134 Chinese patients with psychotic disorders in Hong Kong. The program is a motivational and insight-inducing educational program that addresses patients' awareness and knowledge of schizophrenia and skills of medication management (Gray et al., 2006) . They were randomly assigned to either the medication adherence program or usual psychiatric outpatient care. The patients' levels of medication adherence (using Drug Attitude Inventory, DAI), mental (Positive and Negative Syndrome Scale, PANSS) and psychosocial (Specific Level of Functioning scale, SLOF) functioning, insights into illness (Insight and Treatment Attitude Questionnaire, ITAQ), and re-hospitalization rates (number and length in six months) were measured at recruitment and at one week (Post-test 1) and 12 months (Post-test 2) after the intervention.
Results: Preliminary results of MANOVA test indicated that the participants in the NPP reported significantly overall improvements on the patient outcomes [F (1, 132) = 6.12, p=0.005; Wilks' Lambda= 0.95; a large effect with partial (eta)2 = 0.39]. Post hoc Tukey's HSD test indicated that their mental state (PANSS score), attitude towards medication use (DAI score), and insight into the illness (ITAQ scores) were significantly improved and hospitalization rates (both number and length of re-admissions) were significantly reduced at both one week and 12 months after the intervention, compared with standard care.
Conclusion: The results of this controlled trial can provide evidence of the effectiveness of a community-based adherence therapy for schizophrenia in improving medication adherence, mental condition and insight into the illness and its treatment. This can then result in reducing the risk of relapse and re-admission over 12 months, and hence minimize those tragic events in relation to relapse such as violence and self-harm, as well as the medical and social costs.